Conatus Pharmaceut (CNAT) Earnings
|
Expand Research on CNAT
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -30.9% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -11.3% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 3/7/18 | Q417 | -$0.15 | -$0.17 | +$0.02 | $8.8M | $9.49M | = |  | | Details | |
| 11/1/17 |  |
Q317 | -$0.13 | -$0.05 | -$0.08 | $9.6M | $16.06M | = | | | Details |
| 8/2/17 | Q217 | -$0.19 | -$0.17 | -$0.02 | $10M | $7.75M | = | | | Details | |
| 5/4/17 | |
Q117 | -$0.14 | -$0.22 | +$0.08 | $4.1M | $4.15M | = | | | Details |
| 3/15/17 | |
Q416 | -$0.35 | -$0.26 | -$0.09 | $800M | $1.67M | = | | | Details |
11/8/16  |
Q316 | -$0.31 | -$0.34 | +$0.03 | N/A | N/A | N/A | | | Details | |
| 8/3/16 |
|
Q216 | -$0.30 | -$0.38 | +$0.08 | N/A | N/A | N/A | | | Details |
| 5/5/16 |
|
Q116 | -$0.36 | -$0.35 | -$0.01 | N/A | N/A | N/A | | | Details |
